Can You Get Wegovy If You're Not Overweight? What the Licence Actually Says

Your consultation with a GPhC-registered Independent Prescriber is completely free — a real clinician reads your answers, not a bot.
Once approved, treatment is dispatched the same working day if your order arrives by 12pm Monday to Friday.
Delivery is free, tracked with DPD, and arrives the next working day in plain, unbranded packaging.
One transparent price covers consultation, prescription, treatment and 7-day aftercare, no hidden fees, no subscription, no auto-renewal.

Wegovy (semaglutide) is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above when at least one weight-related health condition is present. If your BMI sits below those thresholds, you fall outside the licensed criteria, and a GPhC-registered prescriber cannot legally issue a prescription for it. That is the direct answer the licence gives. These are prescription-only medicines and, regardless of how they are obtained, UK law requires a clinical assessment before any prescription is written — your own health picture, not a number on a calculator, is what a prescriber actually weighs up.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and UK guidance say about Wegovy eligibility, and the safe, legal route forward

What the licensed BMI thresholds are and why they exist

The NICE appraisal of semaglutide for weight management (NICE TA875) sets out the conditions under which Wegovy may be prescribed on the NHS: adults with a BMI of 35 or above plus at least one weight-related comorbidity, within a specialist multidisciplinary service, for a maximum of two years. Private prescribing follows the medicine's UK marketing authorisation, which is slightly broader: BMI of 30 or above, or 27 to 29.9 with a qualifying condition such as hypertension, dyslipidaemia, obstructive sleep apnoea, type 2 diabetes or prediabetes, or cardiovascular disease. For some ethnic backgrounds, UK guidance applies those thresholds 2.5 kg/m² lower.

Those numbers are not arbitrary gatekeeping. The STEP 1 trial, published in the New England Journal of Medicine, enrolled adults with a BMI of 30 or above and demonstrated an average reduction of around 15% body weight over 68 weeks, results you can explore further if you're looking to buy the Wegovy maintenance dose of 2.4mg. The trial evidence base was built on participants who met those thresholds, the licence reflects where the clinical data actually sits. A prescriber assessing someone below the cut-off has no robust safety or efficacy evidence to draw on, and the MHRA's own guidance is clear that GLP-1 medicines are not assessed for quick or cosmetic weight loss. So if your BMI is currently below 27, the medicine is not licensed for your situation, full stop.

Worth using the NHS BMI calculator to get a precise figure, online estimates can be surprisingly off.

What 'not obese' or borderline BMI actually means for a private consultation

Many people who contact us describe themselves as "not that overweight" but then find, on checking properly, that their BMI does fall within the 27 to 29.9 bracket alongside a qualifying health condition. That combination does meet the licensed criteria. Our page on getting Wegovy if you're not obese goes into that scenario in more detail, it is more common than people expect.

A clinical assessment does not just count kilograms. A GPhC-registered prescriber looks at your full medical history, current conditions, medications and health goals. Someone at BMI 27 with well-managed hypertension may be a good candidate; someone at BMI 31 with a complex medication history may not be. BMI alone never guarantees a prescription, and the absence of an obesity diagnosis does not automatically rule one out. The conversation is the point.

If your BMI genuinely sits below 27 with no qualifying condition, the honest answer is that no legitimate regulated pharmacy in the UK can prescribe Wegovy for you right now, though our dedicated page on how to get Wegovy without being overweight explains the nuances of that position in full. You can read more about the full clinical route onto Wegovy for weight loss, including what happens at a consultation, to see what assessment looks like in practice.

The legal UK route to a Wegovy prescription, and how to check any pharmacy is genuine

The only lawful way to obtain Wegovy in the UK is via a prescription issued after clinical assessment by a registered prescriber. That prescription can come through an NHS specialist service (waiting lists are commonly long), a GP where the new contract allows, or a GPhC-registered online pharmacy carrying out a proper clinical consultation. Before you use any online service, verify it on the GPhC pharmacy register. A registered pharmacy has a premises number you can look up in seconds, ours is 9012878.

The MHRA has warned repeatedly about counterfeit weight-loss pens sold online and via social media, some containing insulin rather than semaglutide, leading to hospitalisations. Around 20 million doses of illegally traded weight-loss medicines (approximately £45 million street value) were seized in 2025 alone, including the first UK site producing counterfeit tirzepatide pens. Sellers offering these medicines without a prescription, or advertising discount codes, are red flags. Report anything suspicious at the MHRA's Yellow Card portal.

At nume, medicines are sourced through the licensed UK supply chain. Every order placed before 12pm on a working day (fits neatly into a weekday morning before the school run) is dispatched the same afternoon, once a prescriber has reviewed and approved it. You can find the full overview of what the process involves on how to get Wegovy in the UK.

If you don't meet the current threshold, what to do next

If your BMI is below 27 and you have no qualifying condition, Wegovy is not the right fit for now. That is not a dead end. The broader weight-loss treatment overview covers other clinically supported options, and it is worth reading through. For people who do sit at or above the threshold, or who are uncertain, a free consultation is the right first step, there is no obligation and no charge to find out where you stand.

If you are already on treatment and thinking about what happens when you stop, our page on coming off Wegovy without regaining weight covers the evidence on what to expect. And if you have wider questions before starting, our FAQs are a practical place to look.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions